CARA

Cara Therapeutics Stock Price

14.72
-0.05 (-0.34%)
Upgrade to Real-Time
Regular Market
14.72

Low
11.22

52 Week Range

High
29.6473

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -0.34% 14.72 13:38:13
Open Price Low Price High Price Close Price Prev Close
14.65 14.30 14.78 14.77
Bid Price Ask Price Spread News
14.72 14.74 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,603 342,549 $ 14.59 $ 4,998,291 - 11.22 - 29.6473
Last Trade Time Type Quantity Stock Price Currency
13:38:45 5 $ 14.73 USD

Period:

Draw Mode:

Cara Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 737.32M 50.09M 49.12M $ 135.08M $ 9.16M 0.18 56.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 138.54k 3.50%

more financials information »

Cara Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CARA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.5215.8314.3015.04630,202-0.80-5.15%
1 Month12.9018.2512.3314.753,674,6781.8214.11%
3 Months14.0418.2511.2214.351,590,4070.684.84%
6 Months18.8629.647311.2216.851,412,223-4.14-21.95%
1 Year15.3029.647311.2216.76939,771-0.58-3.79%
3 Years21.9929.64738.8817.72724,586-7.27-33.06%
5 Years6.1829.64735.8516.131,001,5338.54138.19%

Cara Therapeutics Description

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.


Your Recent History
NASDAQ
CARA
Cara Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.